Prestige Consumer Healthcare

Update in progress

PBH (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Prestige Consumer Healthcare Inc. and its subsidiaries develop, manufacture, market, distribute, and sell OTC health and personal care products in North America, Australia, and internationally. It operates in two segments: North American OTC Healthcare and International OTC Healthcare. The portfolio includes brands such as BC and Goody’s analgesics; Boudreaux’s Butt Paste; Chloraseptic; Clear Eyes; Compound W; Debrox; DenTek; Dramamine; Fleet; Gaviscon; Luden’s; Monistat; Nix; Summer’s Eve; TheraTears; Fess; Hydralyte. Headquartered in Tarrytown, NY; founded 1996. Formerly Prestige Brands Holdings, Inc., renamed in 2018.

Company score

Sentiment: 0.15; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.01; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.13; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.03; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.06; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive